Physician
Pathology Medical Group of Saint John's
Pathology Medical Group of Saint John's was paid $253K by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 12% of everything it billed.
33Billing provider infoPATHOLOGY MEDICAL GROUP OF SAINT JOHN'S
SANTA MONICA, CA 90404
SANTA MONICA, CA 90404
33aNPI1417992868assigned 06/19/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$253K
24GClaims163,131
24DCodes billed70
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#76 of 222
Median peer was paid$42K
This provider vs. median6.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,809 | $13K | |
| 2019 | 9,488 | $14K | |
| 2020 | 13,242 | $26K | |
| 2021 | 37,562 | $66K | |
| 2022 | 30,848 | $47K | |
| 2023 | 30,769 | $49K | |
| 2024incomplete | 29,413 | $38K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 12% | 26,131 | 13,931 | $31K |
| 80053 | Comprehensive metabolic panel | 12% | 21,406 | 12,050 | $31K |
| 83880 | 6.1% | 3,193 | 1,781 | $16K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.3% | 973 | 912 | $13K |
| 83735 | 5.2% | 11,467 | 3,238 | $13K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4.5% | 673 | 601 | $12K |
| 84145 | 4.5% | 3,141 | 1,754 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.4% | 8,947 | 3,371 | $11K |
| 84484 | 4.2% | 6,376 | 4,854 | $11K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.1% | 1,345 | 1,260 | $10K |
| 87040 | 3.1% | 2,904 | 2,231 | $8K | |
| 82330 | 3.1% | 3,850 | 1,811 | $8K |
58 more codes
| 83605 | 2.5% | 3,582 | $6K | |
| 83690 | 2.4% | 5,066 | $6K | |
| 85027 | 1.9% | 4,860 | $5K | |
| 85730 | 1.9% | 3,991 | $5K | |
| 81001 | 1.6% | 8,773 | $4K | |
| 85610 | 1.6% | 6,142 | $4K | |
| 84100 | 1.5% | 5,739 | $4K | |
| 85379 | 1.5% | 2,535 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 1,429 | $4K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.2% | 1,615 | $3K |
| 82803 | 1.1% | 1,017 | $3K | |
| 80306 | <1% | 2,422 | $2K | |
| 82077 | <1% | 1,723 | $2K | |
| 80047 | <1% | 1,773 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,779 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 122 | $2K |
| 87186 | <1% | 1,024 | $1K | |
| 87077 | <1% | 947 | $1K | |
| 86140 | <1% | 1,850 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 297 | $1K |
| 86900 | <1% | 2,306 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 879 | $1K |
| 86901 | <1% | 2,351 | $1K | |
| 86850 | <1% | 1,896 | $995.68 | |
| 80202 | <1% | 444 | $884.56 | |
| 87070 | <1% | 605 | $869.82 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 633 | $848.68 |
| 80179 | <1% | 600 | $683.36 | |
| 80143 | <1% | 636 | $665.74 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 191 | $638.02 |
| 82728 | <1% | 135 | $536.00 | |
| 84702 | <1% | 230 | $530.34 | |
| 87081 | <1% | 488 | $524.60 | |
| 80076 | <1% | 424 | $516.39 | |
| 82550 | <1% | 548 | $513.88 | |
| 83550 | <1% | 459 | $489.90 | |
| 87205 | <1% | 590 | $472.66 | |
| 83540 | <1% | 529 | $456.05 | |
| 83615 | <1% | 540 | $372.38 | |
| 87641 | <1% | 72 | $343.48 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 80 | $308.45 |
| 85384 | <1% | 129 | $302.75 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 71 | $247.66 |
| 87631 | <1% | 41 | $236.52 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 71 | $234.90 |
| 84439 | <1% | 162 | $221.70 | |
| 80061 | Lipid panel | <1% | 112 | $204.64 |
| 85652 | <1% | 413 | $156.06 | |
| 87400 | <1% | 145 | $85.40 | |
| 87430 | <1% | 28 | $45.87 | |
| 82140 | <1% | 15 | $43.21 | |
| 86592 | <1% | 78 | $37.18 | |
| 84703 | <1% | 28 | $16.66 | |
| 85380 | <1% | 28 | $15.35 | |
| 80365 | <1% | 15 | $9.00 | |
| 86880 | <1% | 13 | $8.55 | |
| 0353U | 0% | 24 | $0.00 | |
| 80329 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKRASNE, DAVID (MANAGING PARTNER)